【摘 要】
：
1.Screening Study:Point-of-care glucose testing and a "real-life" metabolic screening checklist were tested in outpatients treated with antipsychotics.The study design was a retrospective,cross-sectio
【机 构】
：
University of Minnesota Duluth-College of Pharmacy USA
【出 处】
：
中国上海第七届国际新药发明科技年会
论文部分内容阅读
1.Screening Study:Point-of-care glucose testing and a "real-life" metabolic screening checklist were tested in outpatients treated with antipsychotics.The study design was a retrospective,cross-sectional,cohort study.A total of 92 (49 women and 43 men) underwent initial screening.Patient data were recorded on a metabolic screening checklist by a pharmacist or nurse.The screening checklist consisted of:demographics,vital signs,(height/weight,BMI,blood pressure,waist and hip circumference,point-of-care random glucose),personal and family knowledge of current illnesses (diabetes,hypertension,hyperlipidemia),modifiable risk factors (smoking,alcohol,level of activity),current medication history and recommendations to the psychiatrist.63 (71%) met criteria for Level 1 metabolic risk (abdominal obesity); of these,38 (60%) met criteria for Level 2 risk (abdominal obesity plus high blood-pressure).Patients with random glucose >140mg/dL had a higher likelihood for being at Level 2 risk than Level 1 risk (X2=5.99,df=1,p=0.014).Overall,five percent of the 92 patients met criteria for "Pre-diabetes Risk".
其他文献
Over 60% of ongoing cell therapy interventions utilize autologous and allogeneic adult stem cells,a large proportion of which are based on mesenchymal stem cells (MSCs).Although a precise definition o
Nearly half of known antibiotics act on the ribosome,an important and enduring antibacterial target.Although its size and complexity have always presented special challenges,X-ray crystallography of r
Classical antibiotics target vital cell functions,but this strategy has led to the development of multi-resistant microbes and we are running out of options to cure such infections.Therefore,novel sol
The glucocorticoid action has been implicated in the development of the Metabolic Syndrome.Systemic glucocorticoid excess induces central obesity,insulin resistance,dyslipidemia and hypertension,the s
Type 2 diabetes is a major health risk in many countries and incidence rates are increasing.Diverse antidiabetic agents are available that act through various mechanisms on different organs.Mechanism-
Compelling animal and human data indicate that stress compromises neurotrophic functions producing neural atrophy and reducing neuroplasticity resulting in dysfunction in brain circuitry associated wi
1.Background Melanin-concentrating hormone (MCH) is a cyclic 19-amino acid neuropeptide that is predominantly expressed in the central nervous system (CNS).It has been demonstrated that MCH plays an i
CRO in India is a recent development,only a decade and half old.The first five years went mostly in capability building and also in trying to gain credibility.During this time the first few pharmaceut
Background:Diabetes Mellitus is a chronic disease prevailing in modem societies.Contributing factors accounted for diabetes include genetic autoimmune dysfunction and excessive intake of energy that l
Hengruis Discovery and Development Programs on Anti-diabetic Clinical Candidate will be discussed including SP2086 Retagliptin which is in Phase Ⅰ clinical trial in US.